Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy

NCT: NCT07132892 · ACTIVE_NOT_RECRUITING

NCT IDNCT07132892
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-01
Completion2027-12-31
SponsorJeffrey M. Kenkel (OTHER)
First posted
Last updated

Brief Summary

The study is being conducted to objectively assess tissue changes following the use of P4HB in rhytidectomy to understand how the utilization of the surgical mesh may affect tissue mechanical strength and elasticity, wound healing, and scar formation dynamics.

Frequently Asked Questions

What is Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy?

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy is a clinical trial registered under NCT07132892. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07132892?

The current status of NCT07132892 (Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy) is: ACTIVE_NOT_RECRUITING.

When did Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy start?

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy started on 2025-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑